155 related articles for article (PubMed ID: 21574852)
1. Providing genetic risk information to parents of newborns with sickle cell trait: role of the general practitioner in neonatal screening.
Vansenne F; de Borgie CA; Legdeur M; Spauwen MO; Peters M
Genet Test Mol Biomarkers; 2011 Oct; 15(10):671-5. PubMed ID: 21574852
[TBL] [Abstract][Full Text] [Related]
2. [Information for parents of children with sickle cell trait detected by neonatal screening: A 10-year experience].
Joly P; Badens C; Fekih S; Philippe N; Merono F; Thuret I; Pondarré C
Arch Pediatr; 2015 May; 22(5):562-3. PubMed ID: 25842198
[No Abstract] [Full Text] [Related]
3. After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands?
Kaufmann JO; Krapels IP; Van Brussel BT; Zekveld-Vroon RC; Oosterwijk JC; van Erp F; van Echtelt J; Zwijnenburg PJ; Petrij F; Bakker E; Giordano PC
Public Health Genomics; 2014; 17(1):16-22. PubMed ID: 24216604
[TBL] [Abstract][Full Text] [Related]
4. Disclosing to parents newborn carrier status identified by routine blood spot screening.
Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
[TBL] [Abstract][Full Text] [Related]
5. General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.
Ram S; Russell B; Gubb M; Taylor R; Butler C; Khan I; Shelling A
N Z Med J; 2012 Oct; 125(1364):14-26. PubMed ID: 23242394
[TBL] [Abstract][Full Text] [Related]
6. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
Burnham-Marusich AR; Ezeanolue CO; Obiefune MC; Yang W; Osuji A; Ogidi AG; Hunt AT; Patel D; Ezeanolue EE
Public Health Genomics; 2016; 19(5):298-306. PubMed ID: 27614873
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening and genetic counseling for sickle cell trait.
Grossman LK; Holtzman NA; Charney E; Schwartz AD
Am J Dis Child; 1985 Mar; 139(3):241-4. PubMed ID: 3976605
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease.
Acharya K; Lang CW; Ross LF
J Natl Med Assoc; 2009 Nov; 101(11):1163-72. PubMed ID: 19998646
[TBL] [Abstract][Full Text] [Related]
10. Knowledge Deficit of Sickle Cell Trait Status: Can Nurses Help?
Arhin AO
Crit Care Nurs Q; 2019; 42(2):198-201. PubMed ID: 30807345
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
O'Leary JD; Odame I; Pehora C; Chakraborty P; Crawford MW
Can J Anaesth; 2013 Jan; 60(1):54-9. PubMed ID: 23104576
[TBL] [Abstract][Full Text] [Related]
12. Using formative research to develop a counselor training program for newborn screening in Ghana.
Treadwell MJ; Anie KA; Grant AM; Ofori-Acquah SF; Ohene-Frempong K
J Genet Couns; 2015 Apr; 24(2):267-77. PubMed ID: 25193810
[TBL] [Abstract][Full Text] [Related]
13. Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.
Loader S; Sutera CJ; Walden M; Kozyra A; Rowley PT
Am J Hum Genet; 1991 Mar; 48(3):447-51. PubMed ID: 1998331
[TBL] [Abstract][Full Text] [Related]
14. [Neonatal screening of hemoglobinopathies in a population residing in Portugal].
Peres MJ; Carreiro MH; Machado MC; Seixas T; Picanço I; Batalha L; Lavinha J; Martins MC
Acta Med Port; 1996; 9(4-6):135-9. PubMed ID: 9005686
[TBL] [Abstract][Full Text] [Related]
15. The current state of sickle cell trait: implications for reproductive and genetic counseling.
Pecker LH; Naik RP
Blood; 2018 Nov; 132(22):2331-2338. PubMed ID: 30487130
[TBL] [Abstract][Full Text] [Related]
16. Campaign to control genetic blood diseases in Bahrain.
Al Arrayed S
Community Genet; 2005; 8(1):52-5. PubMed ID: 15767757
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell carriers' unmet information needs: Beyond knowing trait status.
Mayo-Gamble TL; Schlundt D; Cunningham-Erves J; Murry VM; Bonnet K; Quasie-Woode D; Mouton CP
J Genet Couns; 2019 Aug; 28(4):812-821. PubMed ID: 30969464
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.
Lagoe E; Labella S; Arnold G; Rowley PT
Genet Test; 2005; 9(3):255-60. PubMed ID: 16225405
[TBL] [Abstract][Full Text] [Related]
19. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
20. Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety.
Kladny B; Williams A; Gupta A; Gettig EA; Krishnamurti L
Genet Med; 2011 Jul; 13(7):658-61. PubMed ID: 21546841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
